<p>ImmuCell Corporation（纳斯达克代码：ICCC - 获取免费报告）在周二的交易中跌破了其 200 日移动平均线。该股票的 200 日移动平均线为 6.15 美元，最低交易价为 5.80 美元。ImmuCell 的股票最后交易价为 5.82 美元，成交量为 45,363 股。</p>
<h2>华尔街分析师观点</h2>
<p>另外，Weiss Ratings 在周一的报告中重申了对 ImmuCell 股票的 “卖出（d+）” 评级。一位股票研究分析师对该股票给予了卖出评级，根据 MarketBeat 的数据，ImmuCell 目前的平均评级为 “卖出”。</p>
<p><strong>查看我们关于 ICCC 的最新研究报告</strong></p>
<h2>ImmuCell 价格表现</h2>
<p>该股票的 50 日移动平均线为 5.72 美元，200 日移动平均线为 6.15 美元。该公司的市值为 5267 万美元，市盈率为 22.39，贝塔值为 0.20。公司当前比率为 4.21，速动比率为 1.76，债务股本比率为 0.27。</p>
<p>ImmuCell（纳斯达克代码：ICCC - 获取免费报告）最近在 11 月 13 日（星期四）发布了季度财报。这家生物技术公司报告的每股收益（EPS）为（0.02）美元。ImmuCell 的股本回报率为 8.00%，净利润率为 8.37%。该公司在本季度的收入为 555 万美元。</p>
<h2>对 ImmuCell 的对冲基金观点</h2>
<p>一家对冲基金最近增加了对 ImmuCell 股票的持股。根据该公司在最近向证券交易委员会提交的 13F 文件，Geode Capital Management LLC 在第二季度将其在 ImmuCell Corporation（纳斯达克代码：ICCC - 免费报告）的持股增加了 4.2%。该公司在本季度购买了额外的 2,907 股后，持有 71,852 股生物技术公司的股票。Geode Capital Management LLC 在最近一个季度末持有 ImmuCell 的 0.79%，价值 50 万美元。13.47% 的股票由机构投资者持有。</p>
<h2>关于 ImmuCell</h2>
<p>（获取免费报告）</p>
<p>ImmuCell Corporation（纳斯达克代码：ICCC）是一家生物技术公司，开发、制造和销售旨在增强奶牛和肉牛健康的免疫产品和诊断试剂。公司总部位于缅因州波特兰，专注于通过其被动免疫解决方案和兽医诊断产品支持群体健康管理。</p>
<p>该公司的旗舰产品 CalfGuard 天然初乳补充剂旨在促进新生小牛抗体的被动转移，并减少新生疾病的发生率。</p>
<h2>精选文章</h2>
<ul>
<li>我们更看好的五只股票比 ImmuCell 更好</li>
<li>可能每月支付高达 4,290 美元的无聊 AI 投资</li>
<li>特朗普的 “美国房地产交易” 解析</li>
<li>在 1 月 1 日之前投资 1,000 美元于这只股票 [不是 NVDA]</li>
<li>警报：在 2026 年 1 月之前抛售这五只股票！</li>
<li>特朗普做了什么？？</li>
</ul>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元于 ImmuCell 吗？</h2>
<p>在考虑 ImmuCell 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而 ImmuCell 并不在名单上。</p>
<p>虽然 ImmuCell 目前在分析师中被评为卖出评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>查看这五只股票</p>

ICCC

<p>ImmuCell Corporation 的股票（NASDAQ: ICCC）已跌破其 200 日移动平均线，最低交易价格为 5.80 美元。分析师对该股票给予了 “卖出” 评级，目前市值为 5267 万美元。该公司报告的季度收入为 551 万美元，净利润率为 8.37%。Geode Capital Management 在第二季度增持了 ImmuCell 4.2% 的股份。ImmuCell 专注于动物健康的免疫产品，特别是在奶牛和肉牛领域</p>

<p>ImmuCell Corporation (NASDAQ:ICCC - Get Free Report) crossed below its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of $6.15 and traded as low as $5.80. ImmuCell shares last traded at $5.82, with a volume of 45,363 shares changing hands.</p>
<div class="lb-trans"><p>ImmuCell Corporation（纳斯达克代码：ICCC - 获取免费报告）在周二的交易中跌破了其 200 日移动平均线。该股票的 200 日移动平均线为 6.15 美元，最低交易价为 5.80 美元。ImmuCell 的股票最后交易价为 5.82 美元，成交量为 45,363 股。</p>
</div><h2>Wall Street Analyst Weigh In</h2>
<div class="lb-trans"><h2>华尔街分析师观点</h2>
</div><p>Separately, Weiss Ratings reiterated a &#34;sell (d+)&#34; rating on shares of ImmuCell in a report on Monday. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, ImmuCell presently has an average rating of &#34;Sell&#34;.</p>
<div class="lb-trans"><p>另外，Weiss Ratings 在周一的报告中重申了对 ImmuCell 股票的 “卖出（d+）” 评级。一位股票研究分析师对该股票给予了卖出评级，根据 MarketBeat 的数据，ImmuCell 目前的平均评级为 “卖出”。</p>
</div><p><strong>Check Out Our Latest Research Report on ICCC</strong></p>
<div class="lb-trans"><p><strong>查看我们关于 ICCC 的最新研究报告</strong></p>
</div><h2>ImmuCell Price Performance</h2>
<div class="lb-trans"><h2>ImmuCell 价格表现</h2>
</div><p>The stock has a 50-day moving average of $5.72 and a two-hundred day moving average of $6.15. The firm has a market cap of $52.67 million, a price-to-earnings ratio of 22.39 and a beta of 0.20. The company has a current ratio of 4.21, a quick ratio of 1.76 and a debt-to-equity ratio of 0.27.</p>
<div class="lb-trans"><p>该股票的 50 日移动平均线为 5.72 美元，200 日移动平均线为 6.15 美元。该公司的市值为 5267 万美元，市盈率为 22.39，贝塔值为 0.20。公司当前比率为 4.21，速动比率为 1.76，债务股本比率为 0.27。</p>
</div><p>ImmuCell (NASDAQ:ICCC - Get Free Report) last posted its quarterly earnings data on Thursday, November 13th. The biotechnology company reported ($0.02) earnings per share (EPS) for the quarter. ImmuCell had a return on equity of 8.00% and a net margin of 8.37%.The company had revenue of $5.51 million for the quarter.</p>
<div class="lb-trans"><p>ImmuCell（纳斯达克代码：ICCC - 获取免费报告）最近在 11 月 13 日（星期四）发布了季度财报。这家生物技术公司报告的每股收益（EPS）为（0.02）美元。ImmuCell 的股本回报率为 8.00%，净利润率为 8.37%。该公司在本季度的收入为 555 万美元。</p>
</div><h2>Hedge Funds Weigh In On ImmuCell</h2>
<div class="lb-trans"><h2>对 ImmuCell 的对冲基金观点</h2>
</div><p>A hedge fund recently raised its stake in ImmuCell stock. Geode Capital Management LLC raised its position in shares of ImmuCell Corporation (NASDAQ:ICCC - Free Report) by 4.2% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities &amp; Exchange Commission. The firm owned 71,852 shares of the biotechnology company's stock after purchasing an additional 2,907 shares during the quarter. Geode Capital Management LLC owned 0.79% of ImmuCell worth $500,000 at the end of the most recent quarter. 13.47% of the stock is owned by institutional investors.</p>
<div class="lb-trans"><p>一家对冲基金最近增加了对 ImmuCell 股票的持股。根据该公司在最近向证券交易委员会提交的 13F 文件，Geode Capital Management LLC 在第二季度将其在 ImmuCell Corporation（纳斯达克代码：ICCC - 免费报告）的持股增加了 4.2%。该公司在本季度购买了额外的 2,907 股后，持有 71,852 股生物技术公司的股票。Geode Capital Management LLC 在最近一个季度末持有 ImmuCell 的 0.79%，价值 50 万美元。13.47% 的股票由机构投资者持有。</p>
</div><h2>About ImmuCell</h2>
<div class="lb-trans"><h2>关于 ImmuCell</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>ImmuCell Corporation NASDAQ: ICCC is a biotechnology company that develops, manufactures, and markets immunological products and diagnostic assays designed to enhance animal health in dairy and beef cattle. Headquartered in Portland, Maine, the company focuses on supporting herd health management through its portfolio of passive immunology solutions and veterinary diagnostics.</p>
<div class="lb-trans"><p>ImmuCell Corporation（纳斯达克代码：ICCC）是一家生物技术公司，开发、制造和销售旨在增强奶牛和肉牛健康的免疫产品和诊断试剂。公司总部位于缅因州波特兰，专注于通过其被动免疫解决方案和兽医诊断产品支持群体健康管理。</p>
</div><p>The company's flagship offering, CalfGuard natural colostrum supplement, is formulated to promote the passive transfer of antibodies in newborn calves and reduce the incidence of neonatal diseases.</p>
<div class="lb-trans"><p>该公司的旗舰产品 CalfGuard 天然初乳补充剂旨在促进新生小牛抗体的被动转移，并减少新生疾病的发生率。</p>
</div><h2>Featured Articles</h2>
<div class="lb-trans"><h2>精选文章</h2>
</div><ul>
<li>Five stocks we like better than ImmuCell</li>
<li>The boring AI play that could pay up to $4,290 monthly</li>
<li>Trump’s “real estate deal for America” explained</li>
<li>Put $1,000 into this stock by Jan 1 [Not NVDA]</li>
<li>ALERT: Drop these 5 stocks before January 2026!</li>
<li>Trump Did WHAT??</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票比 ImmuCell 更好</li>
<li>可能每月支付高达 4,290 美元的无聊 AI 投资</li>
<li>特朗普的 “美国房地产交易” 解析</li>
<li>在 1 月 1 日之前投资 1,000 美元于这只股票 [不是 NVDA]</li>
<li>警报：在 2026 年 1 月之前抛售这五只股票！</li>
<li>特朗普做了什么？？</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in ImmuCell Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元于 ImmuCell 吗？</h2>
</div><p>Before you consider ImmuCell, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 ImmuCell 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ImmuCell wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而 ImmuCell 并不在名单上。</p>
</div><p>While ImmuCell currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 ImmuCell 目前在分析师中被评为卖出评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>查看这五只股票</p>
</div>

ImmuCell（NASDAQ:ICCC）股价跌破 200 日移动平均线 - 现在是卖出的时候吗？